We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-9.45%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.13B
AUM Growth
-$263M
Cap. Flow
-$67.3M
Cap. Flow %
-5.93%
Top 10 Hldgs %
53.9%
Holding
81
New
2
Increased
39
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$23.3M
2
BVS icon
Bioventus
BVS
+$12.1M
3
PRTA icon
Prothena Corp
PRTA
+$7.77M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$7.75M
5
SIBN icon
SI-BONE Inc
SIBN
+$7.56M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$60M
2
XENT
Intersect ENT, Inc
XENT
+$27.4M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$18.6M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.2M
5
LITS
Lite Strategy Inc
LITS
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 84.11%
2 Communication Services 6.42%
3 Energy 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
51
Elevance Health
ELV
$81.5B
$611K 0.05%
1,244
– –
ABBV icon
52
AbbVie
ABBV
$443B
$606K 0.05%
3,740
– –
NVST icon
53
Envista
NVST
$4.44B
$574K 0.05%
11,793
– –
CVS icon
54
CVS Health
CVS
$133B
$559K 0.05%
5,519
– –
GSK icon
55
GSK
GSK
$104B
$548K 0.05%
10,059
– –
BMY icon
56
Bristol-Myers Squibb
BMY
$133B
$530K 0.05%
7,256
– –
BDX icon
57
Becton Dickinson
BDX
$45.6B
$502K 0.04%
1,935
– –
AVTR icon
58
Avantor
AVTR
$9.32B
$494K 0.04%
14,596
– –
WAT icon
59
Waters Corp
WAT
$37B
$477K 0.04%
1,536
– –
ITGR icon
60
Integer Holdings
ITGR
$4.12B
$471K 0.04%
5,846
– –
CI icon
61
Cigna
CI
$73.7B
$466K 0.04%
1,943
– –
HUM icon
62
Humana
HUM
$43.7B
$465K 0.04%
1,068
– –
SYNH
63
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$464K 0.04%
5,736
– –
BAX icon
64
Baxter International
BAX
$13.5B
$460K 0.04%
5,929
– –
ICUI icon
65
ICU Medical
ICUI
$4.21B
$454K 0.04%
2,039
– –
HOLX
66
DELISTED
Hologic
HOLX
$449K 0.04%
5,845
– –
NUVA
67
DELISTED
NuVasive, Inc.
NUVA
$445K 0.04%
7,850
– –
UTHR icon
68
United Therapeutics
UTHR
$25.8B
$442K 0.04%
2,466
– –
MCK icon
69
McKesson
MCK
$100B
$412K 0.04%
1,346
– –
GILD icon
70
Gilead Sciences
GILD
$162B
$399K 0.04%
6,705
– –
JNJ icon
71
Johnson & Johnson
JNJ
$618B
$383K 0.03%
2,161
– –
PRGO icon
72
Perrigo
PRGO
$1.4B
$377K 0.03%
9,823
– –
TAK icon
73
Takeda Pharmaceutical
TAK
$54.6B
$367K 0.03%
25,630
– –
SNY icon
74
Sanofi
SNY
$103B
$341K 0.03%
6,650
– –
UHS icon
75
Universal Health Services
UHS
$10.2B
$297K 0.03%
2,050
– –
1 2
3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, First Light Asset Management held 81 positions worth $1.13B, down 19% from $1.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management withdrew a net $67.3M in Q1 2022, closing 6 positions and reducing 9 holdings. Its most notable exit was Arena Pharmaceuticals Inc, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Communication Services and Energy.

Against the trend, First Light Asset Management opened a new position in Bioventus worth $12.7M.

  • First Light Asset Management's largest Q1 2022 buy was Bioventus: 901,525 shares worth $12.7M.
  • First Light Asset Management added most to AtriCure in Q1 2022, an estimated $23.3M increase.
  • First Light Asset Management's biggest Q1 2022 reduction was Intersect ENT, Inc, cutting an estimated $27.4M.
  • First Light Asset Management fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $60M.
  • First Light Asset Management's ten largest holdings make up 54% of its $1.13B portfolio in Q1 2022.
  • First Light Asset Management opened 2 new positions and closed 6 in Q1 2022.
  • First Light Asset Management's portfolio value fell 19% quarter-over-quarter to $1.13B.

Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.